跳至主要内容
临床试验/ISRCTN53375662
ISRCTN53375662进行中(未招募)未知

An observational retrospective cohort study describing clinical outcomes and utilization of healthcare resources among persons with COVID-19 in England, stratified by infection severity and selected comorbidities

AstraZeneca (United Kingdom)0 个研究点目标入组 11,990,730 人开始时间: 2021年10月21日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
11,990,730

研究概览

简要总结

2023 Results article in https://pubmed.ncbi.nlm.nih.gov/38115964/ immunocompromised populations (added 08/01/2024)

研究设计

研究类型
Observational

入排标准

性别
All

入选标准

  • This study will include all subjects in England who were active in all datasets described above for at least 1 day during the COVID-19 infection identification period

排除标准

  • Current participant exclusion criteria as of 16/12/2022:
  • No general exclusion criteria will be applied for defining the overall study population.
  • Previous participant exclusion criteria:
  • Subjects will be excluded from this study if they have less than 12 months of baseline data prior to 1 September 2020

研究者

发起方
AstraZeneca (United Kingdom)

相似试验